Background: Parenteral nutrition (PN) is detrimental for the growth, development and survival of extremely premature babies. We have come a long way in providing nutrition to preterm babies in the ...

The global parenteral nutrition market size was valued at USD 7.38 billion in 2024 and is projected to reach from USD 7.77 billion in 2025 to USD 12.48 billion by 2033, growing at a CAGR of 5.4% ...

While it would seem intuitive that early nutritional intervention is warranted for most patients, the literature to date suggests that early parenteral nutrition (PN) does not improve clinical ...

A randomized, controlled trial was conducted to evaluate the effects of intradialytic parenteral nutrition (IDPN) using ENEFLUID® in malnourished hemodialysis patients. While no changes were ...

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

Nutritional interventions, including nutritional counseling, oral supplements, and intradialytic parenteral nutrition (IDPN), are recommended to address these challenges. On dialysis days ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 61 tables and 74 figures, this 149-page report ?North America Clinical Nutrition Market 2022-2032 by Substrate, ...